ArticleFrontiers in immunology2021

Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.

Leigh Naylor-Adamson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.